MDT Medtronic

Q4 2025 10-Q

Filed: Nov 25, 2025Period ending Oct 24, 2025

Health Care

Electromedical & Electrotherapeutic ApparatusSEC EDGAR

Medtronic (MDT) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Nov 25, 2025 for the fiscal period ending Oct 24, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q4 2025 10-Q

Risk Factors

• No new risk factors added this quarter; risks consistent with prior 10-K filing
• Most material update: impact of armed conflicts on international operations highlighted due to geopolitical tensions

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$9.0B

▲ +6.6% YoY▲ +4.5% QoQ

Net Income

$1.4B

▲ +8.2% YoY▲ +32.1% QoQ

Operating Margin

18.8%

▼ -18bp YoY▲ +196bp QoQ

Net Margin

15.3%

▲ +22bp YoY▲ +321bp QoQ

ROE

2.8%

▲ +21bp YoY

Total Assets

$91.3B

▲ +1.4% YoY

EPS (Diluted)

$1.06

▲ +7.1% YoY▲ +30.9% QoQ

Operating Cash Flow

$925M

▼ -3.4% YoY▼ -15.0% QoQ

Source: XBRL data from Medtronic Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Medtronic Quarterly Reports

Q1 2026 10-Q

Q1 2025 10-Q

Get deeper insights on Medtronic

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.